Global epidemiology of cirrhosis—aetiology, trends and predictions

DQ Huang, NA Terrault, F Tacke, LL Gluud… - Nature reviews …, 2023‏ - nature.com
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors

DQ Huang, P Mathurin, H Cortez-Pinto… - Nature reviews …, 2023‏ - nature.com
Heavy alcohol consumption is a major cause of morbidity and mortality. Globally, alcohol per-
capita consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to …

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

LA Díaz, JP Arab, A Louvet, R Bataller… - Nature Reviews …, 2023‏ - nature.com
Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

ACG clinical guideline: alcohol-associated liver disease

LL Jophlin, AK Singal, R Bataller… - Official journal of the …, 2024‏ - journals.lww.com
Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic
disease and frequent indication for liver transplantation worldwide. With harmful alcohol use …

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022‏ - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

[HTML][HTML] COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management

P Li, Y Liu, Z Cheng, X Yu, Y Li - Biomedicine & Pharmacotherapy, 2022‏ - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

[HTML][HTML] What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: from bench to bedside

P Danpanichkul, K Suparan, D Kim… - Journal of Clinical …, 2024‏ - mdpi.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of
the world's adult population. While it is associated with obesity and metabolic syndrome …

Alcoholic Hepatitis: An experimental meta-analysis

V Shapovalova - SSP Modern Pharmacy and Medicine, 2023‏ - ssp.ee
Addictive drug dependence from psychoactive substances (alcohol, narcotics,
psychotropics) with comorbid disorders against the background of the pandemic is a …

[PDF][PDF] Alcohol-associated liver disease mortality increased from 2017 to 2020 and accelerated during the COVID-19 pandemic

S Deutsch-Link, Y Jiang, AF Peery, AS Barritt… - Clinical …, 2022‏ - Elsevier
Alcohol consumption has risen substantially in the United States (US) in the past two
decades. 1, 2 Alcohol-associated liver disease (ALD) represents a greater inpatient financial …

Changing epidemiology of cirrhosis and hepatic encephalopathy

J Louissaint, S Deutsch-Link… - Clinical Gastroenterology …, 2022‏ - cghjournal.org
The development of hepatic encephalopathy (HE) marks a significant transition in the
natural history of cirrhosis. Following a diagnosis of HE, the median survival for persons with …